Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
213.14
-0.59 (-0.28%)
Nov 26, 2025, 4:00 PM EST - Market closed
Cardinal Health Market Cap
Cardinal Health has a market cap or net worth of $50.64 billion as of November 26, 2025. Its market cap has increased by 73.57% in one year.
Market Cap
50.64B
Enterprise Value
55.08B
1-Year Change
73.57%
Ranking
Category
Stock Price
$213.14
Market Cap Chart
Since December 1, 1998, Cardinal Health's market cap has increased from $13.56B to $50.64B, an increase of 273.42%. That is a compound annual growth rate of 5.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 50.78B | 77.42% |
| Dec 31, 2024 | 28.62B | 15.21% |
| Dec 29, 2023 | 24.84B | 23.29% |
| Dec 30, 2022 | 20.15B | 38.88% |
| Dec 31, 2021 | 14.51B | -7.68% |
| Dec 31, 2020 | 15.72B | 6.23% |
| Dec 31, 2019 | 14.79B | 11.33% |
| Dec 31, 2018 | 13.29B | -31.06% |
| Dec 29, 2017 | 19.28B | -16.32% |
| Dec 30, 2016 | 23.04B | -21.56% |
| Dec 31, 2015 | 29.37B | 9.92% |
| Dec 31, 2014 | 26.72B | 17.11% |
| Dec 31, 2013 | 22.81B | 63.05% |
| Dec 31, 2012 | 13.99B | -0.28% |
| Dec 30, 2011 | 14.03B | 4.95% |
| Dec 31, 2010 | 13.37B | 14.33% |
| Dec 31, 2009 | 11.69B | -5.67% |
| Dec 31, 2008 | 12.40B | -40.63% |
| Dec 31, 2007 | 20.88B | -19.98% |
| Dec 29, 2006 | 26.09B | -11.36% |
| Dec 30, 2005 | 29.44B | 17.18% |
| Dec 31, 2004 | 25.13B | -5.11% |
| Dec 31, 2003 | 26.48B | 1.10% |
| Dec 31, 2002 | 26.19B | -10.16% |
| Dec 31, 2001 | 29.15B | 4.84% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |